BioCurcumin reduces joint pain better than the commonly prescribed prescription drug diclofenac
Curcumin from the plant Turmeric is a great and very safe anti-inflammatory that has been used in many human clinical trials. The problem is that Curcumin is poorly absorbed and it doesn’t last for a very long time in the body. This meant that patients had to take very high doses of Curcumin a number of times each day to achieve relief.
The issue of absorption and dosing was solved with the introduction Curcumin in the form of BioCurcumin. Research at Baylor University Medical Center in Dallas shows that BioCurcumin is absorbed seven to ten times better than regular Curcumin and greater than twice as well as Curcumin Phytosome and it also remains in the body longer for eight to twelve hours for a more sustained benefit. This translates to easy convenient dosing of a capsule or two twice a day with meals.
The drug diclofenac a.k.a. Voltaren™ is frequently prescribed for every form of arthritis including the common osteoarthritis of the knee and the inflammatory rheumatoid arthritis. It is an NSAID in the same family as ibuprofen and naproxen. In a recent study of 2.5 million Danes diclofenac increased the risk of stroke by 86% in people not previously judged to be at risk of stroke. Diclofenac increased the risk of heart attack by 40%. This translates to two out of every one-hundred patients having a heart attack solely because they were taking diclofenac; millions of people take diclofenac daily.
In a head-to-head study run by medical doctors at Baylor University Medical Center 45 patients with rheumatoid arthritis were treated with the herbal ingredient BioCurcumin at a dosage of 500mg twice daily, or with the drug diclofenac sodium at a dosage of 50mg twice daily or a combination of the two for eight weeks. Fourteen percent of the patients dropped out in the diclofenac group due to side effects; no one dropped out of the BioCurcumin group and it was totally safe and nontoxic.
Doctors can base their opinion of the effectiveness of a treatment for this inflammatory arthritis on the DAS 28 Assessment (Disease Activity Score). DAS 28 includes the assessment of joint selling and pain in 28 different joints. BCM worked the best outperforming the combination or the drug diclofenac as the sole treatment.
BioCurcumin was better for relieving joint pain, joint swelling, joint tenderness, joint inflammation, and for improving stiffness and range of motion. Rheumatoid arthritis is a terrible, painful, disfiguring disease that takes away a persons’ mobility, quality of life, and sometimes their independence. BioCurcumin reduced joint pain without any toxicity by 45% where the drug reduced it by 42%.
The VAS Score is the visual analog score. The VAS assessment is the patients own opinion of the quality of a treatment. In the VAS assessment patients state that BioCurcumin improved their disease by 60% and the drug reduced it by 50%; again the herb that is proven to be safe in many human clinical trials outperformed a commonly prescribed and dangerous drug. At the start of the study the total number of diseased joints per patient in the BioCurcumin group dropped from 19 on average to 3 on average. In the drug group it dropped from 18 diseased joints on average to 6 on average. The total number of swollen joints in the herb group dropped from 12 per patient to zero but in the drug group it dropped from 17 to 2. The patients on BioCurcumin had an easier time grooming, dressing, arising out of a chair and walking than the group on diclofenac. The results of this well performed study are published in the journal Phytotherapy Research.